Aug 11, 2026 08:00AM
Jul 29, 2026 08:00AM
Jul 27, 2026 08:00AM
Jul 21, 2026 08:02AM
Jul 21, 2026 08:00AM
Jul 15, 2026 08:00AM
May 27, 2026 08:00AM PharmaTher Evolves Platform Strategy with MEDBOTX(TM) Robotic 3D Printing for Personalized Medicines
Apr 21, 2026 08:00AM
Apr 20, 2026 08:00AM
Apr 16, 2026 08:00AM
Mar 3, 2026 08:00AM
Feb 2, 2026 09:27AM
Jan 14, 2026 08:00AM
Jan 2, 2026 08:00AM PharmaTher CEO Publishes Letter to Shareholders
Dec 2, 2025 09:53AM
Nov 17, 2025 08:00AM
Oct 17, 2025 08:26AM
Oct 16, 2025 08:04AM
Oct 16, 2025 08:00AM
Oct 15, 2025 08:00AM
Oct 8, 2025 08:00AM PharmaTher Provides Update on Ketamine Program for LID-Parkinson's Disease
Aug 27, 2025 08:00AM
Aug 14, 2025 08:02AM
Aug 14, 2025 08:00AM
Aug 11, 2025 09:51AM
Aug 11, 2025 09:49AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM PharmaTher Announces FDA Approval of Ketamine (KETARx™)
Jun 18, 2025 08:00AM
Mar 3, 2025 08:00AM
Sep 19, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 19, 2024 08:00AM
May 15, 2024 08:00AM
May 1, 2024 08:50AM PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
May 2, 2023 07:30AM
Apr 3, 2023 07:00AM
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM
Feb 1, 2023 11:25AM PharmaTher Holdings Submits FDA Meeting Package to Discuss Phase 3 Program and Fast Track Designation for KETARX™ (Ketamine) in Parkinson’s Disease
Jan 18, 2023 08:15AM
Jan 11, 2023 08:15AM
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM
Sep 29, 2022 07:00AM PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal Year Ended May 31, 2022
Sep 16, 2022 07:00AM

330,737 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All